{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["disc herniation", "extrusion", "intervertebral disc", "nucleus pulposus", "ozone therapy"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "34576108", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "22"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "22"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2021", "Month": "09", "Day": "14"}], "ELocationID": ["9946", "10.3390/ijms22189946"], "Journal": {"ISSN": "1422-0067", "JournalIssue": {"Volume": "22", "Issue": "18", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "14"}}, "Title": "International journal of molecular sciences", "ISOAbbreviation": "Int J Mol Sci"}, "ArticleTitle": "Ozone as Modulator of Resorption and Inflammatory Response in Extruded Nucleus Pulposus Herniation. Revising Concepts.", "Abstract": {"AbstractText": ["Ozone therapy has been used to treat disc herniation for more than four decades. There are several papers describing results and mechanism of action. However, it is very important to define the characteristics of extruded disc herniation. Although ozone therapy showed excellent results in the majority of spinal diseases, it is not yet fully accepted within the medical community. Perhaps it is partly due to the fact that, sometimes, indications are not appropriately made. The objective of our work is to explain the mechanisms of action of ozone therapy on the extruded disc herniation. Indeed, these mechanisms are quite different from those exerted by ozone on the protruded disc herniation and on the degenerative disc disease because the inflammatory response is very different between the various cases. Extruded disc herniation occurs when the nucleus squeezes through a weakness or tear in the annulus. Host immune system considers the nucleus material to be a foreign invader, which triggers an immune response and inflammation. We think ozone therapy modulates this immune response, activating macrophages, which produce phagocytosis of extruded nucleus pulposus. Ozone would also facilitate the passage from the M1 to M2 phase of macrophages, going from an inflammatory phase to a reparative phase. Further studies are needed to verify the switch of macrophages."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Argentino de Ozonoterapia (IAOT), Buenos Aires C1425ASG, Argentina."}], "LastName": "Erario", "ForeName": "Mar\u00eda de Los \u00c1ngeles", "Initials": "ML\u00c1"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Argentino de Ozonoterapia (IAOT), Buenos Aires C1425ASG, Argentina."}], "LastName": "Croce", "ForeName": "Eduardo", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Tissue Engineering and Cell Therapy (CIITT), Civil Association for Research and Development of Advanced Therapies (ACIDTA), Buenos Aires C1425DKA, Argentina."}], "LastName": "Moviglia Brandolino", "ForeName": "Maria Teresita", "Initials": "MT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Center for Tissue Engineering and Cell Therapy (CIITT), Civil Association for Research and Development of Advanced Therapies (ACIDTA), Buenos Aires C1425DKA, Argentina."}], "LastName": "Moviglia", "ForeName": "Gustavo", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto Argentino de Ozonoterapia (IAOT), Buenos Aires C1425ASG, Argentina."}], "LastName": "Grangeat", "ForeName": "An\u00edbal M", "Initials": "AM"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Mol Sci", "NlmUniqueID": "101092791", "ISSNLinking": "1422-0067"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Immunologic Factors"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Immunologic Factors"}, {"QualifierName": ["complications", "drug therapy", "immunology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["complications", "drug therapy", "immunology"], "DescriptorName": "Intervertebral Disc Displacement"}, {"QualifierName": ["etiology"], "DescriptorName": "Low Back Pain"}, {"QualifierName": ["drug effects", "immunology", "pathology"], "DescriptorName": "Nucleus Pulposus"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Ozone"}], "CoiStatement": "The authors declare no conflict of interest. "}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Shapiro I.M., Vresilovic E.J., Risbud M.V. Is the spinal motion segment a diarthrodial polyaxially joint: What a nice nucleus like you doing in a joint like this? Bone. 2012;50:771\u2013776. doi: 10.1016/j.bone.2011.12.004.", "ArticleIdList": ["10.1016/j.bone.2011.12.004", "PMC3278538", "22197996"]}, {"Citation": "Jahnke M.R., McDevitt C.A. Proteoglycans of the human intervertebral disc. Electrophoretic heterogeneity of the aggregating proteoglycans of the nucleus pulposus. Biochem. J. 1988;251:347\u2013356. doi: 10.1042/bj2510347.", "ArticleIdList": ["10.1042/bj2510347", "PMC1149009", "3041961"]}, {"Citation": "Rider S.M., Mizuno S., Kang J.D. Molecular Mechanisms of Intervertebral Disc Degeneration. Spine Surg. Relat. Res. 2019;3:1\u201311. doi: 10.22603/ssrr.2017-0095.", "ArticleIdList": ["10.22603/ssrr.2017-0095", "PMC6690117", "31435545"]}, {"Citation": "Adams M.A., Roughley P.J. What is Intervertebral Disc Degeneration, and What Causes It? Spine. 2006;31:2151\u20132161. doi: 10.1097/01.brs.0000231761.73859.2c.", "ArticleIdList": ["10.1097/01.brs.0000231761.73859.2c", "16915105"]}, {"Citation": "Wang F., Gao Z.X., Cai F., Sinkemani A., Xie Z.Y., Shi R., Wei J.N., Wu X.T. Formation, function, and exhaustion of notochordal cytoplasmic vacuoles within intervertebral disc: Current understanding and speculation. Oncotarget. 2017;8:57800\u201357812. doi: 10.18632/oncotarget.18101.", "ArticleIdList": ["10.18632/oncotarget.18101", "PMC5593684", "28915712"]}, {"Citation": "Boos N., Weissbach S., Rohrbach H., Weiler C., Spratt K.F., Nerlich A.G. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine. 2002;27:2631\u20132644. doi: 10.1097/00007632-200212010-00002.", "ArticleIdList": ["10.1097/00007632-200212010-00002", "12461389"]}, {"Citation": "Sun Z., Liu B., Luo Z.J. The Immune Privilege of the Intervertebral Disc: Implications for Intervertebral Disc Degeneration Treatment. Int. J. Med. Sci. 2020;17:685\u2013692. doi: 10.7150/ijms.42238.", "ArticleIdList": ["10.7150/ijms.42238", "PMC7085207", "32210719"]}, {"Citation": "Takada T., Nishida K., Doita M., Kurosaka M. Fas ligand exists on intervertebral disc cells: A potential molecular mechanism for immune privilege of the disc. Spine. 2002;27:1526\u20131530. doi: 10.1097/00007632-200207150-00009.", "ArticleIdList": ["10.1097/00007632-200207150-00009", "12131712"]}, {"Citation": "Kaneyama S., Nishida K., Takada T., Suzuki T., Shimomura T., Maeno K., Kurosaka M., Doita M. Fas ligand expression on human nucleus pulposus cells decreases with disc degeneration processes. J. Orthop. Sci. 2008;13:130\u2013135. doi: 10.1007/s00776-007-1204-4.", "ArticleIdList": ["10.1007/s00776-007-1204-4", "18392917"]}, {"Citation": "Bach F.C., Tellegen A.R., Beukers M., Miranda-Bedate A., Teunissen M., de Jong W.A., de Vries S.A., Creemers L.B., Benz K., Meij B.P., et al. Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: From bench towards bedside. Oncotarget. 2018;9:26507\u201326526. doi: 10.18632/oncotarget.25476.", "ArticleIdList": ["10.18632/oncotarget.25476", "PMC5995168", "29899873"]}, {"Citation": "Kim J.H., Moon H.J., Lee J.H., Kim J.H., Kwon T.H., Park Y.K. Rabbit notochordal cells modulate the expression of inflammatory mediators by human annulus fibrosus cells cocultured with activated macrophage-like THP-1 cells. Spine. 2012;37:1856\u20131864. doi: 10.1097/BRS.0b013e3182579434.", "ArticleIdList": ["10.1097/BRS.0b013e3182579434", "22472811"]}, {"Citation": "Sun Z., Wan Z.Y., Guo Y.S., Wang H.Q., Luo Z.J. FasL on human nucleus pulposus cells prevents angiogenesis in the disc by inducing Fas-mediated apoptosis of vascular endothelial cells. Int. J. Clin. Exp. Path. 2013;6:2376\u20132385. doi: 10.1055/s-0034-1376631.", "ArticleIdList": ["10.1055/s-0034-1376631", "PMC3816806", "24228099"]}, {"Citation": "Liu Z., Sun Z., Wang H.-Q., Ge J., Jiang T.-S., Chen Y.-F., Ma Y., Wang C., Hu S., Samartzis D., et al. FasL Expression on Human Nucleus Pulposus Cells Contributes to the Immune Privilege of Intervertebral Disc by Interacting with Immunocytes. Int. J. Med. Sci. 2013;10:1053\u20131060. doi: 10.7150/ijms.6223.", "ArticleIdList": ["10.7150/ijms.6223", "PMC3691805", "23801893"]}, {"Citation": "Garc\u00eda-Cosamal\u00f3n J., del Valle M.E., Calavia M.G., Garc\u00eda-Su\u00e1rez O., L\u00f3pez-Mu\u00f1iz A., Otero J., Vega J.A. Intervertebral disc, sensory nerves and neurotrophins: Who is who in discogenic pain? J. Anat. 2010;217:1\u201315. doi: 10.1111/j.1469-7580.2010.01227.x.", "ArticleIdList": ["10.1111/j.1469-7580.2010.01227.x", "PMC2913007", "20456524"]}, {"Citation": "Giurazza F., Guarnieri G., Murphy K.J., Muto M. Intradiscal O2O3, Rationale, Injection Technique, Short- and Long-term Outcomes for the Treatment of Low Back Pain Due to Disc Herniation. Can. Assoc. Radiol. J. 2017;68:171\u2013177. doi: 10.1016/j.carj.2016.12.007.", "ArticleIdList": ["10.1016/j.carj.2016.12.007", "28438284"]}, {"Citation": "Fardon D.F. Nomenclature and classification of lumbar disc pathology. Spine. 2001;26:461\u2013462. doi: 10.1097/00007632-200103010-00007.", "ArticleIdList": ["10.1097/00007632-200103010-00007", "11242371"]}, {"Citation": "Fardon D.F., Williams A.L., Dohring E.J., Murtagh F.R., Rothman S.L.G., Sze G.K. Lumbar disc nomenclature: Version 2.0, Recommendations of the combined task forces of the North American Spine Society, the American Society of Spine Radiology and the American Society of Neuroradiology. Spine J. Off. J. N. Am. Spine Soc. 2014;14:2525\u20132545. doi: 10.1016/j.spinee.2014.04.022.", "ArticleIdList": ["10.1016/j.spinee.2014.04.022", "24768732"]}, {"Citation": "Xu Z., Zhou X., Chen G. Expression and Mechanism of Interleukin 1 (IL-1), Interleukin 2 (IL-2), Interleukin 8 (IL-8), BMP, Fibroblast Growth Factor 1 (FGF1), and Insulin-Like Growth Factor (IGF-1) in Lumbar Disc Herniation. Med. Sci. Monit. 2019;25:984\u2013990. doi: 10.12659/MSM.911910.", "ArticleIdList": ["10.12659/MSM.911910", "PMC6371738", "30716059"]}, {"Citation": "Doita M., Kanatani T., Ozaki T., Matsui N., Kurosaka M., Yoshiya S. Influence of macrophage infiltration of herniated disc tissue on the production of matrix metalloproteinases leading to disc resorption. Spine. 2001;26:1522\u20131527. doi: 10.1097/00007632-200107150-00004.", "ArticleIdList": ["10.1097/00007632-200107150-00004", "11462080"]}, {"Citation": "Gr\u00f6nblad M., Virri J., Tolonen J., Seitsalo S., K\u00e4\u00e4p\u00e4 E., Kankare J., Myllynen P., Karaharju E.O. A controlled immunohistochemical study of inflammatory cells in disc herniation tissue. Spine. 1994;19:2744\u20132751. doi: 10.1097/00007632-199412150-00002.", "ArticleIdList": ["10.1097/00007632-199412150-00002", "7899973"]}, {"Citation": "O\u2019Donnell J.L., O\u2019Donnell A.L. Prostaglandin E2 content in herniated lumbar disc disease. Spine. 1996;21:1653\u20131655. doi: 10.1097/00007632-199607150-00007.", "ArticleIdList": ["10.1097/00007632-199607150-00007", "8839467"]}, {"Citation": "Park J.B., Chang H., Kim Y.S. The pattern of interleukin-12 and T-helper types 1 and 2 cytokine expression in herniated lumbar disc tissue. Spine. 2002;27:2125\u20132128. doi: 10.1097/00007632-200210010-00009.", "ArticleIdList": ["10.1097/00007632-200210010-00009", "12394925"]}, {"Citation": "Shamji M.F., Setton L.A., Jarvis W., So S., Chen J., Jing L., Bullock R., Isaacs R.E., Brown C., Richardson W.J. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum. 2010;62:1974\u20131982. doi: 10.1002/art.27444.", "ArticleIdList": ["10.1002/art.27444", "PMC2917579", "20222111"]}, {"Citation": "Djuric N., Yang X., El Barzouhi A., Ostelo R., van Duinen S.G., Lycklama \u00c0 Nijeholt G.J., van der Kallen B.F.W., Peul W.C., Vleggeert-Lankamp C.L.A. Lumbar disc extrusions reduce faster than bulging discs due to an active role of macrophages in sciatica. Acta Neurochir. 2020;162:79\u201385. doi: 10.1007/s00701-019-04117-7.", "ArticleIdList": ["10.1007/s00701-019-04117-7", "PMC6942010", "31802274"]}, {"Citation": "Bobechko W.P., Hirsch C. Auto-immune response to nucleus pulposus in the rabbit. J. Bone Jt. Surg. Br. 1965;47:574\u2013580. doi: 10.1302/0301-620X.47B3.574.", "ArticleIdList": ["10.1302/0301-620X.47B3.574", "14341081"]}, {"Citation": "Habtemariam A., Gronblad M., Virri J., Seitsalo S., Ruuskanen M., Karaharju E. Immunocytochemical localization of immunoglobulins in disc herniations. Spine. 1996;21:1864\u20131869. doi: 10.1097/00007632-199608150-00005.", "ArticleIdList": ["10.1097/00007632-199608150-00005", "8875717"]}, {"Citation": "Satoh K., Konno S., Nishiyama K., Olmarker K., Kikuchi S. Presence and distribution of antigen-antibody complexes in the herniated nucleus pulposus. Spine. 1999;24:1980\u20131984. doi: 10.1097/00007632-199910010-00003.", "ArticleIdList": ["10.1097/00007632-199910010-00003", "10528371"]}, {"Citation": "Gronblad M., Habtemariam A., Virri J., Seitsalo S., Vanharanta H., Guyer R.D. Complement membrane attack complexes in pathologic disc tissues. Spine. 2003;28:114\u2013118. doi: 10.1097/00007632-200301150-00004.", "ArticleIdList": ["10.1097/00007632-200301150-00004", "12544925"]}, {"Citation": "Nygaard O.P., Mellgren S.I., Osterud B. The inflammatory properties of contained and noncontained lumbar disc herniation. Spine. 1997;22:2484\u20132488. doi: 10.1097/00007632-199711010-00004.", "ArticleIdList": ["10.1097/00007632-199711010-00004", "9383853"]}, {"Citation": "Autio R.A., Karppinen J., Niinim\u00e4ki J., Ojala R., Kurunlahti M., Haapea M., Vanharanta H., Tervonen O. Determinants of spontaneous resorption of intervertebral disc herniations. Spine. 2006;31:1247\u20131252. doi: 10.1097/01.brs.0000217681.83524.4a.", "ArticleIdList": ["10.1097/01.brs.0000217681.83524.4a", "16688039"]}, {"Citation": "Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: Time for reassessment. F1000Prime Rep. 2014;6:13. doi: 10.12703/P6-13.", "ArticleIdList": ["10.12703/P6-13", "PMC3944738", "24669294"]}, {"Citation": "Pedersen L.M., Schistad E., Jacobsen L.M., R\u00f8e C., Gjerstad J. Serum levels of the pro-inflammatory interleukins 6 (IL-6) and -8 (IL-8) in patients with lumbar radicular pain due to disc herniation: A 12-month prospective study. Brain Behav. Immun. 2015;46:132\u2013136. doi: 10.1016/j.bbi.2015.01.008.", "ArticleIdList": ["10.1016/j.bbi.2015.01.008", "25653193"]}, {"Citation": "Martinez F.O., Helming L., Gordon S. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009;27:451\u2013483. doi: 10.1146/annurev.immunol.021908.132532.", "ArticleIdList": ["10.1146/annurev.immunol.021908.132532", "19105661"]}, {"Citation": "Djuric N., Lafeber G.C.M., Vleggeert-Lankamp C.L.A. The contradictory effect of macrophage-related cytokine expression in lumbar disc herniations: A systematic review. Eur. Spine J. 2020;29:1649\u20131659. doi: 10.1007/s00586-019-06220-w.", "ArticleIdList": ["10.1007/s00586-019-06220-w", "31768840"]}, {"Citation": "Mart\u00ednez-Qui\u00f1ones J.V., Aso-Escario J., Consolini F., Arregui-Calvo R. Regresi\u00f3n espont\u00e1nea de hernias discales intervertebrales. A prop\u00f3sito de una serie de 37 casos. Neurocirug\u00eda. 2010;21:108\u2013117. doi: 10.1016/S1130-1473(10)70065-8.", "ArticleIdList": ["10.1016/S1130-1473(10)70065-8", "20442973"]}, {"Citation": "Di Mauro R., Cantarella G., Bernardini R., Di Rosa M., Barbagallo I., Distefano A., Longhitano L., Vicario N., Nicolosi D., Lazzarino G., et al. The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases. Int. J. Mol. Sci. 2019;20:634. doi: 10.3390/ijms20030634.", "ArticleIdList": ["10.3390/ijms20030634", "PMC6387239", "30717203"]}, {"Citation": "Gali\u00e8 M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Bocci V., Di Paolo N. Oxygen-ozone therapy in medicine: An update. Blood Purif. 2009;28:373\u2013376. doi: 10.1159/000236365.", "ArticleIdList": ["10.1159/000236365", "19752547"]}, {"Citation": "Bocci V. Oxygen-Ozone Therapy: A Critical Evaluation. Kluwer Academic Publishers; Dordrechit, The Netherlands: 2002."}, {"Citation": "Bocci V., Valacchi G. Free radicals and antioxidants: How to reestablish redox homeostasis in chronic diseases? Curr. Med. Chem. 2013;20:3397\u20133415. doi: 10.2174/0929867311320270005.", "ArticleIdList": ["10.2174/0929867311320270005", "23590717"]}, {"Citation": "Bocci V.A. Scientific and medical aspects of ozone therapy. State Art. Arch. Med. Res. 2006;37:425\u2013435. doi: 10.1016/j.arcmed.2005.08.006.", "ArticleIdList": ["10.1016/j.arcmed.2005.08.006", "16624639"]}, {"Citation": "Bocci V., Borrelli E., Travagli V., Zanardi I. The ozone paradox: Ozone is a strong oxidant as well as a medical drug. Med. Res. Rev. 2009;29:646\u2013682. doi: 10.1002/med.20150.", "ArticleIdList": ["10.1002/med.20150", "19260079"]}, {"Citation": "Bocci V. How a calculated oxidative stress can yield multiple therapeutic effects. Free Radic. Res. 2012;46:1068\u20131075. doi: 10.3109/10715762.2012.693609.", "ArticleIdList": ["10.3109/10715762.2012.693609", "22583557"]}, {"Citation": "de Sire A., Agostini F., Lippi L., Mangone M., Marchese S., Cisari C., Bernetti A., Invernizzi M. Oxygen\u2013Ozone Therapy in the Rehabilitation Field: State of the Art on Mechanisms of Action, Safety and Effectiveness in Patients with Musculoskeletal Disorders. Biomolecules. 2021;11:356. doi: 10.3390/biom11030356.", "ArticleIdList": ["10.3390/biom11030356", "PMC7996934", "33652804"]}, {"Citation": "Smith N.L., Wilson A.L., Gandhi J., Vatsia S., Khan S.A. Ozone therapy: An overview of pharmacodynamics, current research, and clinical utility. Med. Gas Res. 2017;7:212\u2013219.", "ArticleIdList": ["PMC5674660", "29152215"]}, {"Citation": "Sagai M., Bocci V. Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress? Med. Gas Res. 2011;1:29. doi: 10.1186/2045-9912-1-29.", "ArticleIdList": ["10.1186/2045-9912-1-29", "PMC3298518", "22185664"]}, {"Citation": "Re L., Mart\u00ednez-S\u00e1nchez G., Bordicchia M., Malcangi G., Pocognoli A., Morales-Segura M.A., Rothchild J., Rojas A. Is ozone pre-conditioning effect linked to Nrf2/EpRE activation pathway in vivo? A preliminary result. Eur. J. Pharmacol. 2014;742:158\u2013162. doi: 10.1016/j.ejphar.2014.08.029.", "ArticleIdList": ["10.1016/j.ejphar.2014.08.029", "25218903"]}, {"Citation": "Gali\u00e8 M., Costanzo M., Nodari A., Boschi F., Calderan L., Mannucci S., Covi V., Tabaracci G., Malatesta M. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free Radic. Biol. Med. 2018;124:114\u2013121. doi: 10.1016/j.freeradbiomed.2018.05.093.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.05.093", "29864481"]}, {"Citation": "Costanzo M., Cisterna B., Vella A., Cestari T., Covi V., Tabaracci G., Malatesta M. Low ozone concentrations stimulate cytoskeletal organization, mitochondrial activity and nuclear transcription. Eur. J. Histochem. 2015;59:2515. doi: 10.4081/ejh.2015.2515.", "ArticleIdList": ["10.4081/ejh.2015.2515", "PMC4503975", "26150162"]}, {"Citation": "Viebahn-H\u00e4nsler R., Fern\u00e1ndez O.S.L., Fahmy Z. Ozone in Medicine: The Low-Dose Ozone Concept\u2014Guidelines and Treatment Strategies. Ozone Sci. Eng. 2012;34:408\u2013424. doi: 10.1080/01919512.2012.717847.", "ArticleIdList": ["10.1080/01919512.2012.717847"]}, {"Citation": "Gallucci M., Limbucci N., Zugaro L., Barile A., Stavroulis E., Ricci A., Galzio R., Masciocchi C. Sciatica: Treatment with intradiscal and intraforaminal injections of steroid and oxygen-ozone versus steroid only. Radiology. 2007;242:907\u2013913. doi: 10.1148/radiol.2423051934.", "ArticleIdList": ["10.1148/radiol.2423051934", "17209164"]}, {"Citation": "Wang J., Wu M., Lin X., Li Y., Fu Z. Low-Concentration Oxygen/Ozone Treatment Attenuated Radiculitis and Mechanical Allodynia via PDE2A-cAMP/cGMP-NF-\u03baB/p65 Signaling in Chronic Radiculitis Rats. Pain Res. Manag. 2018;2018:5192814. doi: 10.1155/2018/5192814.", "ArticleIdList": ["10.1155/2018/5192814", "PMC6311849", "30651902"]}, {"Citation": "Ozcan S., Muz A., Yildiz Altun A., Onal S.A. Intradiscal ozone therapy for lumbar disc herniation. Cell Mol. Biol. 2018;64:52\u201355. doi: 10.14715/cmb/2018.64.5.8.", "ArticleIdList": ["10.14715/cmb/2018.64.5.8", "29729693"]}, {"Citation": "Ercalik T., Kilic M. Efficacy of Intradiscal Ozone Therapy with or without Periforaminal Steroid Injection on Lumbar Disc Herniation: A Double-Blinded Controlled Study. Pain Physician. 2020;23:477\u2013484. doi: 10.36076/ppj.2020/23/477.", "ArticleIdList": ["10.36076/ppj.2020/23/477", "32967390"]}, {"Citation": "Bocci V., Borrelli E., Zanardi I., Travagli V. The usefulness of ozone treatment in spinal pain. Drug Des. Dev. Ther. 2015;9:2677\u20132685. doi: 10.2147/dddt.s74518.", "ArticleIdList": ["10.2147/dddt.s74518", "PMC4440430", "26028964"]}, {"Citation": "Paoloni M., Di Sante L., Cacchio A., Apuzzo D., Marotta S., Razzano M., Franzini M., Santilli V. Intramuscular oxygen-ozone therapy in the treatment of acute back pain with lumbar disc herniation: A multicenter, randomized, double-blind, clinical trial of active and simulated lumbar paravertebral injection. Spine. 2009;34:1337\u20131344. doi: 10.1097/BRS.0b013e3181a3c18d.", "ArticleIdList": ["10.1097/BRS.0b013e3181a3c18d", "19478653"]}, {"Citation": "Pellican\u00f2 G., Martinelli F., Tavanti V., Bonetti M., Leonardi M., Muto M. The Italian Oxygen-Ozone Therapy Federation (FIO) study on oxygen-ozone treatment of herniated disc. Int. J. Ozone Ther. 2006;6:7\u201315."}, {"Citation": "Bonetti M., Cotticelli B., Fontana A., Guindani M., Leonardi M., Volta G.D. Intraforaminal O2O3 versus periradicular steroidal infiltrations in lower back pain: Randomized controlled study. AJNR Am. J. Neuroradiol. 2005;26:996\u20131000.", "ArticleIdList": ["PMC8158626", "15891150"]}, {"Citation": "Murphy K., Elias G., Steppan J., Boxley C., Balagurunathan K., Victor X., Meaders T., Muto M. Percutaneous Treatment of Herniated Lumbar Discs with Ozone: Investigation of the Mechanisms of Action. J. Vasc. Interv. Radiol. 2016;27:1242\u20131250.e3. doi: 10.1016/j.jvir.2016.04.012.", "ArticleIdList": ["10.1016/j.jvir.2016.04.012", "27363296"]}, {"Citation": "Buric J., Rigobello L., Hooper D. Five- and ten-year follow-up on intradiscal ozone injection for disc herniation. Int. J. Spine Surg. 2014;8:17. doi: 10.14444/1017.", "ArticleIdList": ["10.14444/1017", "PMC4325503", "25694935"]}, {"Citation": "Grangeat A.M. Inflammatory Mechanisms Involved in the Lumbar Disc Herniation with Hydrated Nucleus Pulposus; Proceedings of the III Congress of the Mexican Association of Ozone Therapy; Cancun, Mexico. 10\u201312 November 2011."}, {"Citation": "Grangeat A.M., Erario M.A. Inflammatory Mechanisms Involved in the lumbar disc herniation with hydrated nucleus pulposus (acute herniated disc) and oxygen ozone therapy. A different viewpoint. Int. J. Ozone Ther. 2012;11:9\u201314."}, {"Citation": "Ducusin R.J., Nishimura M., Sarashina T., Uzuka Y., Tanabe S., Otani M. Phagocytosis of bovine blood and milk polymorphonuclear leukocytes after ozone gas administration in vitro. J. Vet. Med. Sci. 2003;65:535\u2013539. doi: 10.1292/jvms.65.535.", "ArticleIdList": ["10.1292/jvms.65.535", "12736440"]}, {"Citation": "Volkhovskaya N.B., Tkachenko S.B., Belopolsky A.A. Modulation of phagocytic activity of blood polynuclear leukocytes with ozonized physiological saline. Bull. Exp. Biol. Med. 2008;146:559\u2013561. doi: 10.1007/s10517-009-0340-6.", "ArticleIdList": ["10.1007/s10517-009-0340-6", "19526090"]}, {"Citation": "Diaz-Luis J., Men\u00e9ndez-Cepero S., Diaz-Luis A., Ascanio-Garc\u00eda Y. In vitro effect of ozone in phagocytic function of leucocytes in peripheral blood. J. Ozone Ther. 2015;1:4. doi: 10.7203/jo3t.1.1.2015.10627.", "ArticleIdList": ["10.7203/jo3t.1.1.2015.10627"]}, {"Citation": "Menendez Cepero S.A., Gonzalez Alvarez R., Ledea Lozano O.E., Hernandez Rosales F.A., Le\u00f3n Fern\u00e1ndez O.S., Diaz G\u00f3mez M.F. Ozono. Aspectos B\u00e1sicos y Aplicaciones Cl\u00ednicas. Primera Edicion. Editorial CENIC; La Habana, Cuba: 2008."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "26"}, {"Year": "2021", "Month": "8", "Day": "24"}, {"Year": "2021", "Month": "8", "Day": "29"}, {"Year": "2021", "Month": "9", "Day": "28", "Hour": "1", "Minute": "18"}, {"Year": "2021", "Month": "9", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["34576108", "PMC8469341", "10.3390/ijms22189946", "ijms22189946"]}}], "PubmedBookArticle": []}